Edwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow EW
Edwards Lifesciences Corporation (EW) Shares outstanding
Edwards Lifesciences Corporation's shares outstanding at the end of fiscal 2025 was $585.8M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $577.6M. Over the past ten years it has ranged from $585.8M (fiscal 2025) to $660.9M (fiscal 2015) — the current reading is the lowest in ten years. Edwards Lifesciences Corporation ranks 6th of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $585.8M | (2.25%) |
| FY2024 | $599.3M | (1.66%) |
| FY2023 | $609.4M | (2.37%) |
| FY2022 | $624.2M | (1.11%) |
| FY2021 | $631.2M | (0.11%) |
| FY2020 | $631.9M | (0.75%) |
| FY2019 | $636.7M | (0.66%) |
| FY2018 | $640.9M | (1.05%) |
| FY2017 | $647.7M | (0.87%) |
| FY2016 | $653.4M | (1.13%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $577.6M | (0.53%) |
| Mar 2026 | $580.7M | (0.87%) |
| Dec 2025 | $585.8M | 0.02% |
| Sep 2025 | $585.7M | (0.37%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BSX Boston Scientific Corporation compare | $1.5B |
| MDT Medtronic PLC compare | $1.3B |
| PHG Koninklijke Philips N.V. compare | $968.6M |
| EW Edwards Lifesciences Corporation | $577.6M |
| GEHC GE HealthCare Technologies Inc. compare | $454.0M |
| DXCM DexCom, Inc. compare | $390.1M |
| SYK Stryker Corporation compare | $386.0M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $192.8M |
| STE STERIS plc compare | $97.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement